Detalhe da pesquisa
1.
Alpelisib for PIK3CA-mutated advanced gynecological cancers: First clues of clinical activity.
Gynecol Oncol
; 183: 61-67, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38518529
2.
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study.
Gynecol Oncol
; 175: 182-189, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37355448
3.
The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study.
J Transl Med
; 20(1): 435, 2022 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36180954
4.
A European, Observational, Prospective Trial of Trabectedin Plus Pegylated Liposomal Doxorubicin in Patients with Platinum-Sensitive Ovarian Cancer.
Oncologist
; 26(4): e658-e668, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33289956
5.
An Italian, multicenter, real-world, retrospective study of first-line pazopanib in unselected metastatic renal-cell carcinoma patients: the 'Pamerit' study.
Jpn J Clin Oncol
; 51(3): 484-491, 2021 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33212499
6.
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study.
Int J Gynecol Cancer
; 31(7): 1031-1036, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33990353
7.
Olaparib as maintenance therapy in patients with BRCA 1-2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome.
Gynecol Oncol
; 156(1): 38-44, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31699415
8.
Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel.
Support Care Cancer
; 28(5): 2435-2442, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32048043
9.
Standardization of CTC AR-V7 PCR assay and evaluation of its role in castration resistant prostate cancer progression.
Prostate
; 79(1): 54-61, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30141201
10.
Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results.
J Transl Med
; 17(1): 296, 2019 08 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31464635
11.
Biological Pathways Involved in Tumor Angiogenesis and Bevacizumab Based Anti-Angiogenic Therapy with Special References to Ovarian Cancer.
Int J Mol Sci
; 18(9)2017 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28906427
12.
Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: post-hoc analysis of the Meet-URO 15 study.
Front Oncol
; 14: 1307635, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38410103
13.
Trabectedin as single agent in the salvage treatment of heavily treated ovarian cancer patients: a retrospective, multicenter study.
Gynecol Oncol
; 130(3): 505-10, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23774301
14.
Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab.
JAMA Netw Open
; 6(11): e2345185, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38010650
15.
Effect of systemic therapies or best supportive care after disease progression to both nivolumab and cabozantinib in metastatic renal cell carcinoma: The Meet-Uro 19BEYOND study.
Cancer Med
; 11(16): 3084-3092, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35312175
16.
Immunotherapy and Sonpavde score validation in advanced upper tract urothelial carcinoma: a retrospective study by the Italian Network for Research in Urologic-Oncology (Meet-URO group).
Immunotherapy
; 14(2): 107-114, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34784782
17.
Role of Bone Metastases in Patients Receiving Immunotherapy for Pre-Treated Urothelial Carcinoma: The Multicentre, Retrospective Meet-URO-1 Bone Study.
Clin Genitourin Cancer
; 20(2): 155-164, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35000876
18.
First-line pazopanib in patients with advanced non-clear cell renal carcinoma: An Italian case series.
World J Clin Oncol
; 12(11): 1037-1046, 2021 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34909398
19.
Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b).
Front Oncol
; 11: 682449, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34168997
20.
Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study).
Clin Med Insights Oncol
; 15: 11795549211021667, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34290538